JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on October 6, 2006
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
281/40/29479    most recent
M600579200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, G.
Right arrow Articles by Mulder, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, G.
Right arrow Articles by Mulder, K. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print August 4, 2006
J. Biol. Chem, 10.1074/jbc.M600579200
Submitted on January 19, 2006
Revised on August 2, 2006
Accepted on August 4, 2006

Requirement of Smad3 and CREB-1 in mediating TGFbeta induction of TGFbeta 3 secretion

Guangming Liu, Wei Ding, Jill Neiman, and Kathleen M. Mulder

Pharmacology, Pennsylvania State College of Medicine, Hershey, PA 17033

Corresponding Author: kmm15{at}psu.edu

Since increased TGFbeta production by tumor cells contributes to cancer progression through paracrine mechanisms, identification of critical points that can be targeted to block TGFbeta production is important. Previous studies have identified the precise signaling components and promoter elements required for TGFbeta induction of TGFbeta 1 expression in epithelial cells (J. Biol. Chem. 275, 30765-30773, 2000). In order to determine how regulation of TGFbeta 3 expression differs from that of TGFbeta 1, we identified the precise signaling pathways and transcription factor binding sites that are required for TGFbeta 3 gene expression. Using mutational analysis in electrophoresis mobility shift assays (EMSAs), we demonstrated that the c-AMP-responsive element (CRE) site in the TGFbeta 3 promoter was required for TGFbeta -inducible TGFbeta 3 expression. EMSA supershift assays indicated that CRE binding protein 1 (CREB1) and Smad3 were the major components present in this TGFbeta -inducible complex. Further, using chromatin immunoprecipitation (ChIP) assays, we demonstrated that CREB-1, ATF-2, and c-Jun bound constitutively at the TGFbeta 3 promoter (–100 to +1), whereas Smad3 bound at this site only after TGFbeta stimulation. In addition, inhibition of Jun N-terminal kinase (JNK) and p38 suppressed TGFbeta induction of TGFbeta 3 transactivation, while inhibition of extracellular signal-regulated kinase (ERK) and protein kinase A (PKA) had no effect. Small interfering RNA (siRNA)-CREB1 and siRNA-Smad3 significantly inhibited TGFbeta stimulation of TGFbeta 3 promoter reporter activity and TGFbeta 3 production. Our results indicate that TGFbeta activation of the TGFbeta 3 promoter CRE site, which leads to TGFbeta 3 production, is required TGFbeta RII, JNK, p38, and Smad3, but was independent of PKA, ERK, and Smad4.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D.-W. Lin, I.-C. Chang, A. Tseng, M.-L. Wu, C.-H. Chen, C. A. Patenaude, M. D. Layne, and S.-F. Yet
Transforming Growth Factor {beta} Up-regulates Cysteine-rich Protein 2 in Vascular Smooth Muscle Cells via Activating Transcription Factor 2
J. Biol. Chem., May 30, 2008; 283(22): 15003 - 15014.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. P. Gaide Chevronnay, P. B. Cornet, D. Delvaux, P. Lemoine, P. J. Courtoy, P. Henriet, and E. Marbaix
Opposite Regulation of Transforming Growth Factors-{beta}2 and -{beta}3 Expression in the Human Endometrium
Endocrinology, March 1, 2008; 149(3): 1015 - 1025.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Jin, W. Ding, and K. M. Mulder
Requirement for the Dynein Light Chain km23-1 in a Smad2-dependent Transforming Growth Factor-beta Signaling Pathway
J. Biol. Chem., June 29, 2007; 282(26): 19122 - 19132.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
B. S. Yoon, R. Pogue, D. A. Ovchinnikov, I. Yoshii, Y. Mishina, R. R. Behringer, and K. M. Lyons
BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways
Development, December 1, 2006; 133(23): 4667 - 4678.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.